Addex Therapeutics (ADXN) vs KALA BIO (KALA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
KALA BIO is the larger company by market cap ($5.7 million vs $5.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADXN | KALA |
|---|---|---|
| Share price | $3.02 | $0.294 |
| Market cap | $5.29M | $5.69M |
| 1-day change | -5.03% | -0.88% |
| EPS (TTM) | $-7.56 | $-10.71 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.97 | $95.50 |
| 52-week low | $2.56 | $0.286 |
| Distance from 52-week high | -74.77% | -99.69% |
| Average volume | 138.20K | 1.46M |
| Shares outstanding | 1.75M | 19.34M |
| Employees | 3 | 6 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Addex Therapeutics
ADXN stock →Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
About KALA BIO
KALA stock →KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
ADXN vs KALA FAQ
Which is bigger, Addex Therapeutics or KALA BIO?
KALA BIO (KALA) is larger, with a market capitalization of $5.69M compared with $5.29M for Addex Therapeutics (ADXN).
Are Addex Therapeutics and KALA BIO in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.